Evidence
Research led by scientists at the Universities of Oxford, Cambridge, Copenhagen, Bristol and California (Berkeley) reveals the evolutionary origins of multiple sclerosis (MS). This new insight into the genetic architecture of this disease changes scientists’ view of its causes and has implications for its treatment, as well as paving the way for further investigations into other diseases.
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases
🌐 90 Days
VR Related Evidence Matrix
- Dissecting Parkinson's disease with long-read RNA-sequencing
- The complement system in neurodegenerative diseases
- Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Understanding and manipulating the T-cell response to peptide-MHC
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Innate immune activation in neurodegenerative diseases
- Recruitment, Retention, and Training of Citizen Scientists in Translational Medicine Research: A Citizen Science Initiative on Non-Alcoholic Fatty Liver Disease
- Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Protocol for a comprehensive pipeline to study ancient human genomes
- Mitochondrial DNA Disorders: the (long and winding) road to treatment
- Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models
- Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
- Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans
- Rituximab treatment in pediatric-onset multiple sclerosis
- Building Equitable Neuroscience Research Collaborations in Resource-limited Settings
- Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022
- Recognising the importance and impact of Imaging Scientists: Global guidelines for establishing career paths within core facilities
- New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
- Innovative pharmacotherapy for hepatic metabolic and chronic inflammatory diseases in China
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- Ground-breaking study reveals how COVID-19 vaccines prevent severe disease
- Dementias Platform UK: Bringing genetics into life
- Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases
- Presentation: Regulating Advanced AI Systems - Oxford Martin AI Governance Initiative
- Cystatins: unravelling the biological implications for neuroprotection
- Cystatins: unravelling the biological implications for neuroprotection
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- Potential for New Therapeutic Approaches by Targeting Lactate and pH Mediated Epigenetic Dysregulation in Major Mental Diseases
- Physiological aging and inflammation-induced cellular senescence may contribute to oligodendroglial dysfunction in MS
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Association between CNS-active drugs and risk of Alzheimer's and age-related neurodegenerative diseases
- Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study
- Brain inflammation in experimental autoimmune encephalomyelitis induced in Dark Agouti rats with spinal cord homogenate
- Understanding exosomes: Part 2-Emerging leaders in regenerative medicine
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- Kaempferol efficacy in metabolic diseases: Molecular mechanisms of action in diabetes mellitus, obesity, non-alcoholic fatty liver disease, steatohepatitis, and atherosclerosis
- Cerebellum and Aging: Update and Challenges
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Real-world persistence of multiple sclerosis disease-modifying therapies
- The relationship between 11 different polygenic longevity scores, parental lifespan, and disease diagnosis in the UK Biobank
- Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
- Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review
- Loss of GDE2 leads to complex behavioral changes including memory impairment
- Advancing amyotrophic lateral sclerosis disease diagnosis: A lab-on-chip electrochemical immunosensor for ultra-sensitive TDP-43 protein detection and monitoring in serum patients'
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- The genetic architecture of multimodal human brain age
- Senescence: A DNA damage response and its role in aging and Neurodegenerative Diseases
- TRP Channels in Excitotoxicity
- Shared molecular mechanisms and transdiagnostic potential of neurodevelopmental disorders and immune disorders
- Shared molecular mechanisms and transdiagnostic potential of neurodevelopmental disorders and immune disorders
- Shared molecular mechanisms and transdiagnostic potential of neurodevelopmental disorders and immune disorders
- New heart disease calculator could save lives by identifying high-risk patients missed by current tools
- California Cannabis Research Briefing, April 2023: Meeting Summary
- Right Brain: The Unraveling
Evidence Blueprint
Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases
🌐 365 Days
VR Related Evidence Matrix
- Remote collaborations deliver fewer scientific breakthroughs, says Oxford co-led research
- Dissecting Parkinson's disease with long-read RNA-sequencing
- The complement system in neurodegenerative diseases
- Changes in iron load in specific brain areas lead to neurodegenerative diseases of the central nervous system
- Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases-A Systematic Review
- Six Oxford social scientists scoop top awards for world-leading research
- Understanding and manipulating the T-cell response to peptide-MHC
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Primary lateral sclerosis
- A review of the clinical progress on helminths and their derivative products in autoimmune disease
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
- The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- A comprehensive update on genetic inheritance, epigenetic factors, associated pathology, and recent therapeutic intervention by gene therapy in schizophrenia
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- The risk of secondary progressive multiple sclerosis is geographically determined but modifiable
- Pathology of neurodegenerative disease for the general neurologist
- Oxford Vaccine Group, Department of Paediatrics, University of Oxford receives £7.8 million in research funding to fight pandemic and epidemic threats
- New study reveals source of largest ever Mars quake
- Border-associated macrophages in the central nervous system
- GABA-Transaminase: A Key Player and Potential Therapeutic Target for Neurological Disorders
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease
- New technique identifies earliest cases of genetic disorders from ancient DNA
- Euthanasia and assisted suicide in neurological diseases: a systematic review
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Innate immune activation in neurodegenerative diseases
- Researchers extract ancient DNA from a 2,900-year-old clay brick, revealing a time capsule of plant life
- Evaluation of the feasibility and acceptability of an integrative group psychological intervention for people with Multiple Sclerosis: A study protocol
- Recruitment, Retention, and Training of Citizen Scientists in Translational Medicine Research: A Citizen Science Initiative on Non-Alcoholic Fatty Liver Disease
- Concurrent gliomas in patients with multiple sclerosis
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Ancient DNA reveals genetic admixture in China during tiger evolution
- Protocol for a comprehensive pipeline to study ancient human genomes
- Characterization of cortico-meningeal translocator protein expression in multiple sclerosis
- ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease
- Six Oxford University scientists win Royal Society of Chemistry Prizes
- B cell depletion attenuates CD27 signaling of T helper cells in multiple sclerosis
- Mitochondrial DNA Disorders: the (long and winding) road to treatment
- Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models
- Pharmacological and Non-pharmacological Approaches for the Management of Neuropathic Pain in Multiple Sclerosis
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
- Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
- Evidence supports a causal association between allele-specific vitamin D receptor binding and multiple sclerosis among Europeans
- Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
- Role of the UNC13 family in human diseases: A literature review
- Rituximab treatment in pediatric-onset multiple sclerosis
- Building Equitable Neuroscience Research Collaborations in Resource-limited Settings
- Rare neurovascular genetic and imaging markers across neurodegenerative diseases
- Emerging roles of epigenetics in lead-induced neurotoxicity
- Visualization and analysis of mapping knowledge domains for optic neuritis: a bibliometric research from 2013 to 2022
- Recognising the importance and impact of Imaging Scientists: Global guidelines for establishing career paths within core facilities
- Translation dysregulation in neurodegenerative diseases: a focus on ALS
- Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)
- Toward identifying key mechanisms of progression in multiple sclerosis